Manish R. Sharma, Yonina R. Murciano-Goroff, Ofra Maimon, Yuichi Ando, Sun Young Rha, Manabu Muto, Do-Youn Oh, Gladys Morrison Thiele, Junvie Pailden, Manal Mehibel, Theodore S. Jennaro, Nancy Zhang, Graham Walker, Vivek Subbiah, David S. Hong. "A phase 2 study of telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with advanced solid tumors harboring
                    <i>MET</i>
                    amplification.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps3157